These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 114063)

  • 1. Decrease in serum prolactin by naloxone: evidence against antidopamine and antipsychotic effects.
    Gold MS; Pottash AL; Extein I; Redmond DE; Kleber HD
    Am J Psychiatry; 1979 Oct; 136(10):1339-40. PubMed ID: 114063
    [No Abstract]   [Full Text] [Related]  

  • 2. The effects of opiate agonist and antagonist on serum prolactin in primates: possible role for endorphins in prolactin regulation.
    Gold MS; Redmond DE; Donabedian RK
    Endocrinology; 1979 Jul; 105(1):284-9. PubMed ID: 221205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increase in serum prolactin by exogenous and endogenous opiates: evidence for antidopamine and antipsychotic effects.
    Gold MS; Redmond DE; Donabedian RK; Goodwin FK; Extein I
    Am J Psychiatry; 1978 Nov; 135(11):1415-6. PubMed ID: 30292
    [No Abstract]   [Full Text] [Related]  

  • 4. The effects of opiate agonists on growth hormone and prolactin release in rats.
    Shaar CJ; Clemens JA
    Fed Proc; 1980 Jun; 39(8):2539-43. PubMed ID: 6247214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopaminergic mediation of beta-endorphin-induced prolactin secretion.
    Van Loon GR; De Souza EB; Shin SH
    Neuroendocrinology; 1980 Oct; 31(4):293-6. PubMed ID: 6252497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delayed activation of tuberoinfundibular dopamine neurons and suppression of prolactin secretion in the rat after morphine administration.
    Gudelsky GA; Passaro E; Meltzer HY
    J Pharmacol Exp Ther; 1986 Mar; 236(3):641-5. PubMed ID: 3950867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opioid effects on plasma concentrations of luteinizing hormone and prolactin in the adult male rhesus monkey.
    Gilbeau PM; Almirez RG; Holaday JW; Smith CG
    J Clin Endocrinol Metab; 1985 Feb; 60(2):299-305. PubMed ID: 2981242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dynorphin A1-13 causes elevation of serum levels of prolactin through an opioid receptor mechanism in humans: gender differences and implications for modulation of dopaminergic tone in the treatment of addictions.
    Kreek MJ; Schluger J; Borg L; Gunduz M; Ho A
    J Pharmacol Exp Ther; 1999 Jan; 288(1):260-9. PubMed ID: 9862779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Animal prolactin evidence for antipsychotic activity of piperoxane.
    Gold MS; Redmond DE; Donabedian RK
    Lancet; 1977 Jul; 2(8028):96-7. PubMed ID: 69186
    [No Abstract]   [Full Text] [Related]  

  • 10. Naloxone-induced jumping activity in morphine-dependent mice: a pharmacological study on the role of DA2 receptors.
    Cerbo R; Boni B; De Lena C; Cesarino F; Meco G; Feliciani M; Formisano R; Casacchia M
    Boll Soc Ital Biol Sper; 1984 Mar; 60(3):493-9. PubMed ID: 6712813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opioids and the pulsatile prolactin secretory pattern: effects of hyperprolactinemia.
    Lafuente A; Marco J; Esquifino AI
    Vet Hum Toxicol; 1994 Dec; 36(6):524-8. PubMed ID: 7900271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolactin secretion, a measurable central effect of opiate-receptor antagonists.
    Gold MS; Redmond DE; Donabedian RK
    Lancet; 1978 Feb; 1(8059):323-4. PubMed ID: 75353
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of naloxone and morphine on the proestrous surge of prolactin and gonadotropins in the rat.
    Ieiri T; Chen HT; Campbell GA; Meites J
    Endocrinology; 1980 May; 106(5):1568-70. PubMed ID: 6767598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased serum prolactin in opiate withdrawal and dopaminergic hyperactivity.
    Gold MS; Sweeney DR; Pottash AL; Kleber HD
    Am J Psychiatry; 1979 Jun; 136(6):849-50. PubMed ID: 443478
    [No Abstract]   [Full Text] [Related]  

  • 15. Role of dopaminergic system in opioid-induced cardiovascular responses in dogs.
    Agarwal RK; Pandey US; Dixit KS; Shukla N; Singh SK
    Indian J Med Sci; 1989 Dec; 43(12):323-8. PubMed ID: 2632409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical evidence for multiple dopamine receptors in man.
    Meltzer HY
    Commun Psychopharmacol; 1979; 3(6):457-70. PubMed ID: 44694
    [No Abstract]   [Full Text] [Related]  

  • 17. Opiate and dopamine receptors in the isolated nictitating membrane of the cat.
    Illés P; Knoll J
    Pol J Pharmacol Pharm; 1978; 30(2-3):293-304. PubMed ID: 209424
    [No Abstract]   [Full Text] [Related]  

  • 18. Opiates, prolactin, and the dopamine receptor.
    Tolis G; Dent R; Guyda H
    J Clin Endocrinol Metab; 1978 Jul; 47(1):200-3. PubMed ID: 263291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endorphins, lithium, and naloxone: their relationship to pathological and drug-induced manic-euphoric states.
    Gold MS; Byck R
    NIDA Res Monogr; 1978; (19):192-209. PubMed ID: 218105
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of morphine, naloxone and an enkephalin analogue on plasma prolactin, growth hormone, insulin and thyroxine in goats [proceedings].
    Hart IC; Cowie AT
    J Endocrinol; 1978 May; 77(2):16P-17P. PubMed ID: 660036
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.